Aeshah A. Awaji

555 total citations
25 papers, 273 citations indexed

About

Aeshah A. Awaji is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Aeshah A. Awaji has authored 25 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Aeshah A. Awaji's work include Synthesis and biological activity (5 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (3 papers). Aeshah A. Awaji is often cited by papers focused on Synthesis and biological activity (5 papers), Cancer-related molecular mechanisms research (4 papers) and RNA modifications and cancer (3 papers). Aeshah A. Awaji collaborates with scholars based in Saudi Arabia, Egypt and United States. Aeshah A. Awaji's co-authors include Mohamed M. Abdel‐Daim, Fouad Damiri, Amany A. Sayed, Md. Habibur Rahman, Mousa O. Germoush, Hamdan S. Al-malky, Mohammed Z. Nasrullah, Mohammed Berrada, Raviteja Bulusu and Vaskuri G. S. Sainaga Jyothi and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Aeshah A. Awaji

20 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aeshah A. Awaji Saudi Arabia 9 72 58 58 43 35 25 273
Philemon Ubanako South Africa 11 106 1.5× 93 1.6× 70 1.2× 19 0.4× 42 1.2× 31 361
Nhu‐Thuy Trinh Vietnam 9 28 0.4× 80 1.4× 58 1.0× 24 0.6× 25 0.7× 18 290
So Hee Nam South Korea 11 51 0.7× 166 2.9× 93 1.6× 30 0.7× 22 0.6× 23 371
Nazima Haider India 10 27 0.4× 96 1.7× 72 1.2× 54 1.3× 15 0.4× 46 328
Pinal Chaudhari India 11 165 2.3× 100 1.7× 71 1.2× 40 0.9× 12 0.3× 16 383
Haiyang Hu China 7 70 1.0× 106 1.8× 154 2.7× 44 1.0× 29 0.8× 18 415
Sara Demartis Italy 9 165 2.3× 85 1.5× 102 1.8× 24 0.6× 79 2.3× 14 366
Antonella Barone Italy 13 89 1.2× 142 2.4× 69 1.2× 15 0.3× 37 1.1× 19 392
Abdulrahman A. Halwani Saudi Arabia 9 92 1.3× 87 1.5× 104 1.8× 66 1.5× 16 0.5× 16 419

Countries citing papers authored by Aeshah A. Awaji

Since Specialization
Citations

This map shows the geographic impact of Aeshah A. Awaji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aeshah A. Awaji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aeshah A. Awaji more than expected).

Fields of papers citing papers by Aeshah A. Awaji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aeshah A. Awaji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aeshah A. Awaji. The network helps show where Aeshah A. Awaji may publish in the future.

Co-authorship network of co-authors of Aeshah A. Awaji

This figure shows the co-authorship network connecting the top 25 collaborators of Aeshah A. Awaji. A scholar is included among the top collaborators of Aeshah A. Awaji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aeshah A. Awaji. Aeshah A. Awaji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Khalifa, Mohamed M., et al.. (2025). Discovery of potent anticancer tricarboxamide analogs linked to 1,2,3-triazole, promoting EGFR and VEGFR downregulation. New Journal of Chemistry. 49(23). 9858–9873. 3 indexed citations
2.
Umar, Haruna Isiyaku, et al.. (2025). In silico study of selected alkaloids as dual inhibitors of β- and γ-secretases for Alzheimer's disease. Journal of Alzheimer s Disease. 103(4). 1191–1215.
3.
Eltamany, Elsayed H., Ahmed T. A. Boraei, Mohamed Reda Aouad, et al.. (2025). Novel Benzimidazole‐1,2,3‐Triazole Hybrids: Synthesis, Dual Antimicrobial, Anticancer Activity, Mechanistic Insights, and Computational Studies. ChemistrySelect. 10(15). 5 indexed citations
4.
5.
Awaji, Aeshah A., et al.. (2025). Biochemical analysis of miR-217 and miR-532 in patients with fibromyalgia. European journal of medical research. 30(1). 85–85.
6.
Aborode, Abdullahi Tunde, et al.. (2025). RNA binding proteins (RBPs) on genetic stability and diseases. PubMed. 12(1). 100032–100032.
7.
Shaker, Olfat, et al.. (2025). Serum Circ‐DLGAP4 and miR‐9 as Potential Biomarkers in Pancreatic Cancer. Journal of Clinical Laboratory Analysis. 39(16). e70076–e70076.
8.
Awaji, Aeshah A., et al.. (2024). Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies. Pathology - Research and Practice. 256. 155223–155223. 8 indexed citations
9.
Aborode, Abdullahi Tunde, et al.. (2024). Predictive identification and design of potent inhibitors targeting resistance-inducing candidate genes from E. coli whole-genome sequences. SHILAP Revista de lepidopterología. 4. 1411935–1411935. 3 indexed citations
10.
Shaker, Olfat, et al.. (2024). LncRNA NEAT1 and miRNA 101 as potential diagnostic biomarkers in patients with alopecia areata. Non-coding RNA Research. 10. 35–40. 3 indexed citations
11.
Awaji, Aeshah A., Mohamed Alswah, Mohamed M. Elsebaei, et al.. (2024). N- and s-substituted Pyrazolopyrimidines: A promising new class of potent c-Src kinase inhibitors with prominent antitumor activity. Bioorganic Chemistry. 145. 107228–107228. 12 indexed citations
12.
Biswas, Partha, Shabana Bibi, Qudsia Yousafi, et al.. (2023). Study of MDM2 as Prognostic Biomarker in Brain-LGG Cancer and Bioactive Phytochemicals Inhibit the p53-MDM2 Pathway: A Computational Drug Development Approach. Molecules. 28(7). 2977–2977. 14 indexed citations
13.
Alswah, Mohamed, Mohamed M. Elsebaei, Ashraf H. Bayoumi, et al.. (2023). Development of Novel Class of Phenylpyrazolo[3,4-d]pyrimidine-Based Analogs with Potent Anticancer Activity and Multitarget Enzyme Inhibition Supported by Docking Studies. International Journal of Molecular Sciences. 24(19). 15026–15026. 4 indexed citations
14.
Alswah, Mohamed, Ahmed El-morsy, Ashraf H. Bayoumi, et al.. (2023). Design, Synthesis, In Vitro, and In Silico Studies of New N5-Substituted-pyrazolo[3,4-d]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors. Pharmaceuticals. 16(11). 1593–1593. 7 indexed citations
15.
16.
Elshanbary, Alaa Ahmed, Anas Zakarya Nourelden, Khaled Mohamed Ragab, et al.. (2022). The diagnostic accuracy of intraoperative frozen section biopsy for diagnosis of sentinel lymph node metastasis in breast cancer patients: a meta-analysis. Environmental Science and Pollution Research. 29(32). 47931–47941. 12 indexed citations
17.
Aborode, Abdullahi Tunde, Helen Huang, Wireko Andrew Awuah, et al.. (2022). Approaching COVID‐19 with epidemiological genomic surveillance and the sustainability of biodiversity informatics in Africa. Journal of Medical Virology. 95(1). e28308–e28308. 10 indexed citations
18.
Damiri, Fouad, Md. Habibur Rahman, Mehrukh Zehravi, et al.. (2022). MXene (Ti3C2Tx)-Embedded Nanocomposite Hydrogels for Biomedical Applications: A Review. Materials. 15(5). 1666–1666. 61 indexed citations
19.
Shaker, Olfat, et al.. (2020). Serum long noncoding RNAs FAS-AS1 & PVT1 are novel biomarkers for systemic lupus erythematous. British Journal of Biomedical Science. 77(4). 208–212. 15 indexed citations
20.
Awaji, Aeshah A., Abeer M. Shaaban, Sandeep Kumar Shukla, et al.. (2015). Evaluation of the role of MCPH1 and p53 expression in response to chemotherapy and subsequent survival in breast cancer. Annals of Oncology. 26. iii15–iii15. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philemon Ubanako Breakdown of academic impact, for papers by Nhu‐Thuy Trinh Breakdown of academic impact, for papers by So Hee Nam Breakdown of academic impact, for papers by Nazima Haider Breakdown of academic impact, for papers by Pinal Chaudhari Breakdown of academic impact, for papers by Haiyang Hu Breakdown of academic impact, for papers by Sara Demartis Breakdown of academic impact, for papers by Antonella Barone Breakdown of academic impact, for papers by Abdulrahman A. Halwani
Rankless by CCL
2026